Biognosys
ExitedProteome research
Biognosys has raised €4.4M across 1 funding round, most recently a Series C round in Jul 2017. Based in Switzerland; active in Healthtech. Acquired by Bruker Corporation in 2023. Data as of 31 Oct 2026.
Total raised
€4.4M
€4,397,924
Funding rounds
1
Investors
0
distinct backers
Active since
2017-07
latest 2017-07
Funding by year
EUR raised per yearBiognosys — funding by year — interactive chart.
Data table
| Biognosys — funding by year | |
|---|---|
| 2017 | €4.4M |
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-07-04 | Series C | €4.4M | — | View deal → |
Exit
Type
acquisition
Date
Jan 2023
Value
—
Acquiror
Bruker Corporation (United States of America)
Related news
- Brucker acquires a majority stake in Biognosysstartupticker.ch · 2023-01
- finsmes.com
Similar companies
same sector, similar sizeGlobal coverage: FundingData